Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement system regulatory proteins are a group of soluble and membrane-bound proteins that tightly control the activation and activity of the complement system to prevent unwarranted damage to host tissues while enabling efficient immune defense against pathogens[1][2][3][6][13]. They function at various points in the complement cascade by inhibiting protease activity, accelerating the decay of enzyme complexes, acting as cofactors to inactivate key complement fragments, or blocking the formation of the membrane attack complex[1][3][12]. These regulators are essential for maintaining immune homeostasis; deficiencies or dysfunctions can result in severe autoimmunity, chronic inflammation, increased infection sensitivity, or facilitate tumor immune evasion[1][6].
Inhibition of complement activation at various points in the cascade; Decay acceleration of C3/C5 convertase complexes; Cofactor activity for serine protease Factor I to inactivate C3b/C4b; Preventing membrane attack complex (MAC) formation on host cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement system regulatory protein.